Nucleix Appoints Meirav Chovav Vice President of Strategic Affairs and to the Board of...(verage of the biotechnology/life science...)

Date:8/17/2009

verage of the biotechnology/life science sector as a Wall Street equity research analyst, serving as a senior biotechnology analyst/Managing Director of the health care groups at UBS, Credit Suisse First Boston and Salomon Smith Barney (Citigroup). For ten consecutive years (1994-2003), until she left the equity research field, she was ranked on the Institutional Investor "All-America Research Team" in the biotechnology sector. Ms. Chovav has also been recognized by The Wall Street Journal as the best stock picker in the biotechnology sector in the "Best on the Street" survey and by Bloomberg.

About Nucleix

Nucleix, an emerging life science company specializing in forensic DNA analysis, has developed a "DNA authentication" assay for forensic casework samples with potential applications across multiple DNA analysis and validation fields. DNA fingerprinting has been established as one of the most important forensic tools in criminal investigations. Nucleix scientists have demonstrated the viability of creating artificial DNA and "biological identify theft.(1)" Using basic equipment and know-how, DNA with any desired profile can be fabricated in the lab, and this artificial DNA can then be planted in crime scenes as fake evidence. Until recently, there has been no way to distinguish between genetic profiles obtained from falsified DNA samples, which can appear identical to real biological profiles based on current analytical protocols and technologies. Nucleix's proprietary assays can distinguish between "fake" (in-vitro synthesized) DNA, and "real" (in-vivo generated) DNA. The company is committed to developing state-of-the-art "DNA authentication" assays that can be integrated into the standard forensic procedure, in order to maintain the high credibility of DNA evidence in the courtroom and other uses. For additional information on Nucleix, please visit the company's website at'/>"/>

SOURCE Nucleix, Ltd. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Spectral appoints new board member
2. Cellular Dynamics International Appoints Leroy Hood, M.D., Ph.D., and George Church, Ph.D., to its Scientific Advisory Board
3. China Sky One Medical, Inc. Appoints New Independent Director
4. Omeros Appoints New Vice President of Clinical Development
5. Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
6. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
7. Brookstone Pharmaceuticals Appoints New Corporate Position
8. PDI Appoints Gerald P. Belle as Lead Independent Director
9. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
10. Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer
11. Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board